Terms: = Lung cancer AND CCND3, P30281, 896, ENSG00000112576
153 results:
1. A rare case of TFEB/6p21/VEGFA-amplified renal cell carcinoma diagnosed by whole-exome sequencing: clinicopathological and genetic feature report and literature review.
Zhang R; Ding M; Zhu X; Li X; Hu Q; Tao L; Hu W; Zou H
Diagn Pathol; 2024 May; 19(1):66. PubMed ID: 38730456
[TBL] [Abstract] [Full Text] [Related]
2. Exploring the efficacy and molecular mechanism of Danhong injection comprehensively in the treatment of idiopathic pulmonary fibrosis by combining meta-analysis, network pharmacology, and molecular docking methods.
Wu X; Li W; Luo Z; Chen Y
Medicine (Baltimore); 2024 May; 103(19):e38133. PubMed ID: 38728523
[TBL] [Abstract] [Full Text] [Related]
3. Influence of
Naqash AR; Floudas CS; Aber E; Maoz A; Nassar AH; Adib E; Choucair K; Xiu J; Baca Y; Ricciuti B; Alessi JV; Awad MM; Kim C; Judd J; Raez LE; Lopes G; Nieva JJ; Borghaei H; Takebe N; Ma PC; Halmos B; Kwiatkowski DJ; Liu SV; Mamdani H
JCO Precis Oncol; 2024 Feb; 8():e2300371. PubMed ID: 38330261
[TBL] [Abstract] [Full Text] [Related]
4. Concordance of assessments of four PD-L1 immunohistochemical assays in esophageal squamous cell carcinoma (ESCC).
Wang X; He J; Li J; Wu C; Yue M; Niu S; Jia Y; Jia Z; Cai L; Liu Y
J Cancer Res Clin Oncol; 2024 Jan; 150(2):43. PubMed ID: 38280970
[TBL] [Abstract] [Full Text] [Related]
5. A novel sub-regional radiomics model to predict immunotherapy response in non-small cell lung carcinoma.
Peng J; Zou D; Zhang X; Ma H; Han L; Yao B
J Transl Med; 2024 Jan; 22(1):87. PubMed ID: 38254087
[TBL] [Abstract] [Full Text] [Related]
6. Multi-classification model incorporating radiomics and clinic-radiological features for predicting invasiveness and differentiation of pulmonary adenocarcinoma nodules.
Sun H; Zhang C; Ouyang A; Dai Z; Song P; Yao J
Biomed Eng Online; 2023 Nov; 22(1):112. PubMed ID: 38037082
[TBL] [Abstract] [Full Text] [Related]
7. Development of an Electronic Health Record-Based Algorithm for Predicting lung cancer Screening Eligibility in the Population-Based Research to Optimize the Screening Process lung Research Consortium.
Burnett-Hartman AN; Powers JD; Hixon BP; Carroll NM; Frankland TB; Honda SA; Saia C; Rendle KA; Greenlee RT; Neslund-Dudas C; Zheng Y; Vachani A; Ritzwoller DP
JCO Clin Cancer Inform; 2023 Sep; 7():e2300063. PubMed ID: 37910824
[TBL] [Abstract] [Full Text] [Related]
8. Metastases to the pituitary gland: insights from the German pituitary tumor registry.
Haberbosch L; Schmid S; Hubertus V; Soll D; Acker G; Dottermusch M; Jensen M; Maurer L; Spranger J; Mai K; Vajkoczy P; Saeger W; Strasburger CJ
Pituitary; 2023 Dec; 26(6):708-715. PubMed ID: 37899389
[TBL] [Abstract] [Full Text] [Related]
9. Single-cell sequencing reveals the landscape of the human brain metastatic microenvironment.
Song Q; Ruiz J; Xing F; Lo HW; Craddock L; Pullikuth AK; Miller LD; Soike MH; O'Neill SS; Watabe K; Chan MD; Su J
Commun Biol; 2023 Jul; 6(1):760. PubMed ID: 37479733
[TBL] [Abstract] [Full Text] [Related]
10. Patterns of care for people with small cell lung cancer in Victoria, 2011-19: a retrospective, population-based registry data study.
Huang J; Faisal W; Brand M; Smith S; Alexander M; Briggs L; Conron M; Duffy M; John T; Langton D; Lesage J; MacManus M; Mitchell P; Olesen I; Parente P; Philip J; Samuel E; Torres J; Underhill CR; Zalcberg JR; Harden S; Stirling R
Med J Aust; 2023 Aug; 219(3):120-126. PubMed ID: 37365486
[TBL] [Abstract] [Full Text] [Related]
11. Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium.
Thakar MS; Logan BR; Puck JM; Dunn EA; Buckley RH; Cowan MJ; O'Reilly RJ; Kapoor N; Satter LF; Pai SY; Heimall J; Chandra S; Ebens CL; Chellapandian D; Williams O; Burroughs LM; Saldana BD; Rayes A; Madden LM; Chandrakasan S; Bednarski JJ; DeSantes KB; Cuvelier GDE; Teira P; Gillio AP; Eissa H; Knutsen AP; Goldman FD; Aquino VM; Shereck EB; Moore TB; Caywood EH; Lugt MTV; Rozmus J; Broglie L; Yu LC; Shah AJ; Andolina JR; Liu X; Parrott RE; Dara J; Prockop S; Martinez CA; Kapadia M; Jyonouchi SC; Sullivan KE; Bleesing JJ; Chaudhury S; Petrovic A; Keller MD; Quigg TC; Parikh S; Shenoy S; Seroogy C; Rubin T; Decaluwe H; Routes JM; Torgerson TR; Leiding JW; Pulsipher MA; Kohn DB; Griffith LM; Haddad E; Dvorak CC; Notarangelo LD
Lancet; 2023 Jul; 402(10396):129-140. PubMed ID: 37352885
[TBL] [Abstract] [Full Text] [Related]
12. Pan-cancer and cross-population genome-wide association studies dissect shared genetic backgrounds underlying carcinogenesis.
Sato G; Shirai Y; Namba S; Edahiro R; Sonehara K; Hata T; Uemura M; ; Matsuda K; Doki Y; Eguchi H; Okada Y
Nat Commun; 2023 Jun; 14(1):3671. PubMed ID: 37340002
[TBL] [Abstract] [Full Text] [Related]
13. High-risk Prognostic Tumor Features of Squamous Cell Carcinomas in Organ Transplant Recipients Compared With the General Population.
Pandeya N; Isbel N; Campbell S; Chambers DC; Hopkins P; Soyer HP; Jiyad Z; Plasmeijer EI; Whiteman DC; Olsen CM; Green AC
JAMA Dermatol; 2023 Aug; 159(8):854-858. PubMed ID: 37314794
[TBL] [Abstract] [Full Text] [Related]
14. CT-based radiomics models may predict the early efficacy of microwave ablation in malignant lung tumors.
Zhu F; Yang C; Xia Y; Wang J; Zou J; Zhao L; Zhao Z
Cancer Imaging; 2023 Jun; 23(1):60. PubMed ID: 37308918
[TBL] [Abstract] [Full Text] [Related]
15. Comparison and fusion prediction model for lung adenocarcinoma with micropapillary and solid pattern using clinicoradiographic, radiomics and deep learning features.
Wang F; Wang CL; Yi YQ; Zhang T; Zhong Y; Zhu JJ; Li H; Yang G; Yu TF; Xu H; Yuan M
Sci Rep; 2023 Jun; 13(1):9302. PubMed ID: 37291251
[TBL] [Abstract] [Full Text] [Related]
16. Treatments for non-small cell lung cancer: a systematic quality assessment of clinical practice guidelines.
Cortés-Jofré M; Madera M; Tirado-Amador L; Asenjo-Lobos C; Bonfill-Cosp X
Clin Transl Oncol; 2023 Dec; 25(12):3541-3555. PubMed ID: 37254015
[TBL] [Abstract] [Full Text] [Related]
17. Risk-based screening for second primary extrapulmonary malignancies in stage I lung cancer patients: A study based on SEER database.
Wang T; Zhou J; Zheng Q; Wu D; Lu T; Lin M; Pu Q; Mei J; Liu L
Lung Cancer; 2023 Jun; 180():107218. PubMed ID: 37146472
[TBL] [Abstract] [Full Text] [Related]
18. Multiregional radiomics of brain metastasis can predict response to EGFR-TKI in metastatic NSCLC.
Fan Y; Wang X; Dong Y; Cui E; Wang H; Sun X; Su J; Luo Y; Yu T; Jiang X
Eur Radiol; 2023 Nov; 33(11):7902-7912. PubMed ID: 37142868
[TBL] [Abstract] [Full Text] [Related]
19. Practice-Level Variation in Molecular Testing and Use of Targeted Therapy for Patients With Non-Small Cell lung cancer and Colorectal cancer.
Roberts TJ; Kehl KL; Brooks GA; Sholl L; Wright AA; Landrum MB; Keating NL
JAMA Netw Open; 2023 Apr; 6(4):e2310809. PubMed ID: 37115543
[TBL] [Abstract] [Full Text] [Related]
20. Sarcopenic obesity by the ESPEN/EASO criteria for predicting mortality in advanced non-small cell lung cancer.
Zhou J; Luo L; Xie L; Hu S; Tan L; Lei X; Luo X; Yang M
Clin Nutr; 2023 Jun; 42(6):817-824. PubMed ID: 37084468
[TBL] [Abstract] [Full Text] [Related]
[Next]
